3.5 Diabetes, Metabolic Syndrome & Obesity

ACSM Certified Clinical Exercise Physiologist ACSM-CEP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 The ACSM-CEP Role, Job Definition & Scope of Practice 1.2 Exam Format, Domain Weights & Scoring 1.3 Eligibility, Study Planning & Test-Day Strategy

2 Applied Exercise Physiology & Metabolic Calculations

Bioenergetics & Energy Systems (ATP-PC, glycolytic, oxidative) Acute Cardiorespiratory & Metabolic Responses to Aerobic Exercise Responses to Resistance Exercise & Chronic Training Adaptations ACSM Metabolic Equations, METs & Interpreting VO₂ / RER / Ventilatory Threshold

3 Pathophysiology of Clinical Populations

3.1 Coronary Artery Disease, Myocardial Infarction & Revascularization (PCI/CABG) 3.2 Heart Failure, Valvular Disease & Cardiac Rhythm Disorders 3.3 Hypertension, Dyslipidemia & Peripheral Artery Disease 3.4 Pulmonary Disease: COPD, Asthma & Restrictive/Interstitial Disorders 3.5 Diabetes, Metabolic Syndrome & Obesity 3.6 Renal Disease & Musculoskeletal/Orthopedic Conditions 3.7 Neuromuscular, Neurological & Cognitive Conditions (stroke, MS, Parkinson's, SCI) 3.8 Neoplastic, Immunologic & Hematologic Disorders (cancer, HIV/AIDS, anemia)

4 Clinical ECG Interpretation

4.1 ECG Leads, Waveforms, Rate & Rhythm Determination 4.2 Arrhythmias & Conduction Blocks 4.3 Ischemia, Injury & Infarction (ST changes, exercise-induced) 4.4 Drug & Electrolyte ECG Effects; Resting/Exercise Monitoring Setup & Lead Placement

5 Pharmacology for the Clinical Exercise Physiologist

5.1 Beta-Blockers, Calcium-Channel Blockers & Nitrates 5.2 RAAS Agents, Diuretics, Antiarrhythmics, Lipid-Lowering & Antithrombotic Drugs 5.3 Bronchodilators, Corticosteroids, Insulin & Oral Antidiabetic Agents 5.4 Medication Effects on HR/BP & Exercise Response; Dose/Meal/Dialysis Timing

6 Patient Assessment (Domain I, 18%)

6.1 Medical Records, HIPAA/HITRUST, Charting & Physician Referral 6.2 Patient Interview, Medical History & Medication Reconciliation 6.3 Resting Vital Signs, Body Composition & Resting ECG 6.4 Preparticipation Health Screening & Level of Monitoring (PAR-Q+, ACSM algorithm, ACC/AHA · GOLD · ADA · AACVPR) 6.5 Assessing Patient Goals, Readiness & Psychosocial Status

7 Clinical Exercise Testing (Domain II, 18%)

Submaximal Aerobic Tests (treadmill, cycle, step, 6-minute walk) Musculoskeletal Fitness, Mobility & Balance Testing Maximal Symptom-Limited GXT: Protocols, Contraindications & ECG Prep Test Termination: Relative & Absolute Indications Interpreting & Reporting Results (ECG response, RPP, claudication, Duke Treadmill Score, VO₂/RER/AT)

8 Exercise Prescription for Clinical Populations (Domain III, 22%)

FITT-VP Principles, Progression & Prescription Foundations Ex Rx for Cardiovascular Disease (CAD, HF, HTN, PAD, post-revascularization) Ex Rx for Pulmonary Disease (COPD, asthma; breathing techniques, supplemental O2) Ex Rx for Diabetes, Metabolic Syndrome & Obesity Ex Rx for Musculoskeletal, Neuromuscular, Neoplastic & Other Conditions Communicating Intensity (THR, RPE, talk test), Monitoring & Modifying the Prescription

9 Exercise Training & Leadership (Domain IV, 24%)

9.1 Discussing the Training Plan, Clinician & Patient Expectations/Goals 9.2 Instructing & Modifying Exercise Modes (cardiorespiratory, strength/endurance, flexibility, coordination, agility) 9.3 Patient Monitoring & Supervision During Exercise (telemetry, oximetry, glucometry, ECG) 9.4 Contraindications to Training & Modifying Recommendations 9.5 Documenting Clinical Status, Reporting Adverse Events & Interdisciplinary Coordination

10 Education & Behavior Change (Domain V, 13%)

10.1 Behavioral-Health Screening & Recognizing Distress (PHQ-9, Beck, SF-36; referral) 10.2 Patient Education, Health Literacy & Disease Self-Management 10.3 Motivational Interviewing & Behavior-Change Theories (Transtheoretical, HBM, Social Cognitive, Five-A's) 10.4 Promoting Adherence, Self-Efficacy, Relapse Prevention & Social Support

11 Legal, Professional & Emergency Management (Domain VI, 5%)

11.1 Emergency Equipment, Crash Cart Inspection & Emergency Procedures 11.2 CPR/AED/BLS/ACLS, Universal Precautions & EMS Activation 11.3 Scope of Practice, Legal/Ethical Standards, Liability/Negligence, Informed Consent & Professional Organizations (ACSM/AACVPR/AHA)

3.5 Diabetes, Metabolic Syndrome & Obesity

Key Takeaways Explain This Topic AI

Type 1 diabetes is autoimmune beta-cell destruction causing absolute insulin deficiency; type 2 diabetes involves insulin resistance plus progressive relative insulin deficiency.

Diagnostic criteria for diabetes include A1C >=6.5%, fasting plasma glucose >=126 mg/dL, or 2-hour OGTT glucose >=200 mg/dL.

Metabolic syndrome is diagnosed when 3 of 5 criteria are met: elevated waist circumference, triglycerides >=150 mg/dL, low HDL, blood pressure >=130/85 mmHg, and fasting glucose >=100 mg/dL.

Acute exercise increases skeletal-muscle glucose uptake through insulin-independent GLUT4 translocation, which is why exercise can precipitate hypoglycemia in patients using insulin or sulfonylureas.

Diabetic peripheral neuropathy, autonomic neuropathy, and proliferative retinopathy each require specific exercise modifications for foot safety, heart-rate-based prescription, and Valsalva/high-intensity avoidance, respectively.

Last updated: July 2026

Diabetes, metabolic syndrome, and obesity form an interconnected cluster of cardiometabolic conditions that are among the most common comorbidities seen in clinical exercise practice.

Type 1 vs. Type 2 Diabetes Mellitus

Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of pancreatic beta cells , producing an absolute insulin deficiency . Patients depend on exogenous insulin for survival and are at risk for diabetic ketoacidosis (DKA) if insulin is inadequate, since without insulin the body shifts to unrestrained fat breakdown and ketone production. Type 2 diabetes mellitus (T2DM) begins with insulin resistance in skeletal muscle, liver, and adipose tissue; the pancreas initially compensates with increased insulin secretion, but beta-cell function progressively declines over years, producing a relative insulin deficiency . T2DM is strongly associated with obesity, physical inactivity, and genetic predisposition.

Diagnostic criteria (any one confirms diabetes): A1C >=6.5% , fasting plasma glucose >=126 mg/dL , 2-hour plasma glucose >=200 mg/dL during a 75-g oral glucose tolerance test (OGTT), or a random plasma glucose >=200 mg/dL with classic hyperglycemic symptoms.

Metabolic Syndrome

Metabolic syndrome describes a cluster of cardiometabolic risk factors that, together, substantially raise cardiovascular and diabetes risk. Using harmonized criteria, the diagnosis requires at least 3 of the following 5 :

• Elevated waist circumference (population/ethnicity-specific threshold)
• Triglycerides >=150 mg/dL
• Reduced HDL cholesterol ( <40 mg/dL in men, <50 mg/dL in women )
• Blood pressure >=130/85 mmHg
• Fasting glucose >=100 mg/dL

Insulin resistance is the common thread linking these five components, and each is independently modifiable through structured exercise and lifestyle change.

Exercise and Glucose Regulation

During acute exercise, contracting skeletal muscle takes up glucose through insulin-independent GLUT4 transporter translocation to the cell membrane, meaning exercise lowers blood glucose even when circulating insulin is limited. This is therapeutically valuable but also the source of the primary acute risk: in patients using insulin or insulin secretagogues (sulfonylureas) , this exercise-driven glucose uptake, layered on top of exogenous/stimulated insulin action, can precipitate hypoglycemia , both during exercise and for several hours afterward as muscle glycogen is replenished. Conversely, in T1DM patients with insufficient circulating insulin , exercise in a hyperglycemic, ketotic state can worsen hyperglycemia and accelerate ketosis rather than lower glucose — as a general safety rule, exercise should be deferred if pre-exercise blood glucose is markedly elevated (commonly cited around 250 mg/dL or higher) with ketones present.

Diabetic Complications Relevant to Exercise Prescription

Complication Exercise implication

Peripheral neuropathy Loss of protective sensation increases risk of unnoticed foot trauma/ulceration; daily foot inspection and proper footwear are essential; weight-bearing exercise is still generally appropriate unless active ulceration is present

Autonomic neuropathy Blunts heart-rate response to exercise (chronotropic incompetence-like pattern), increases risk of orthostatic hypotension, and can mask anginal warning symptoms (silent ischemia)

Retinopathy (proliferative) High-intensity exercise, heavy resistance training, and Valsalva maneuvers should be avoided or modified because sharp blood-pressure spikes raise the risk of vitreous hemorrhage or retinal detachment

Nephropathy Exercise is generally beneficial but intensity should be individualized alongside overall CKD management (see renal disease content)

Obesity

Obesity, generally classified by body mass index (BMI >=30 kg/m^2), commonly coexists with insulin resistance, metabolic syndrome, and T2DM, and independently raises orthopedic loading during weight-bearing exercise and impairs thermoregulation and heat dissipation during exercise. Exercise programming for patients with obesity often benefits from non-weight-bearing or reduced-impact modes (cycling, aquatic exercise) to manage joint loading while still achieving meaningful caloric expenditure.

Safety Considerations

Check pre-exercise blood glucose whenever feasible, particularly for insulin-treated patients, and have a fast-acting carbohydrate source available to treat hypoglycemia. Time exercise sessions with awareness of insulin peak action and recent meals to reduce hypoglycemia risk, inspect the feet of patients with known neuropathy, and avoid high-intensity or Valsalva-heavy resistance work in patients with untreated proliferative retinopathy.

Exercise Prescription Principles for Diabetes and Obesity

Current guidance (consistent with the ADA Standards of Care in Diabetes) supports combining regular aerobic exercise with resistance training, since the two modes improve insulin sensitivity through complementary mechanisms — aerobic exercise primarily through GLUT4-mediated glucose uptake and cardiorespiratory adaptation, resistance training through increased skeletal-muscle mass, which expands the body's total capacity for glucose disposal. Reducing prolonged sedentary time, independent of formal exercise sessions, is also an increasingly emphasized recommendation, since even brief bouts of movement every 30 minutes can blunt post-meal glucose excursions. For patients with obesity, gradual progression of exercise volume, attention to appropriate footwear and joint-friendly surfaces, and realistic goal-setting around modest, sustainable weight loss (rather than aggressive short-term targets) improve both safety and long-term adherence.